A futuristic “DNA origami” vaccine platform may one day outperform mRNA shots while being easier to produce and distribute. Credit: Shutterstock Scientists have developed a new DNA origami–based ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

The study offers one of the most detailed maps yet of how human antibody responses vary from person to person.

Machine learning reveals unique COVID vaccine immune signatures in people living with HIV, with differences in antibodies, cytokines, and T cell responses.

Leveragen, Inc., a Boston-based biotechnology company advancing next-generation in vivo antibody discovery, announced today the issuance of a patent in Japan covering core innovations underlying its ...

Wyss Institute's DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against ...

Anthony Wong is a Post-Doctoral Fellow at the University of British Columbia that receives funding from Canadian Institutes of Health Research (CIHR), Health Research BC, and Canadian Biomedical ...

When food is scarce, stress hormones direct the immune system to operate in "low power" mode to preserve immune function while conserving energy, according to researchers at Weill Cornell Medicine.

Read more about Nanoparticle and AI-driven vaccines target broad protection against emerging threats on Devdiscourse ...

Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...